# Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy

> **NCT01693185** · PHASE4 · COMPLETED · sponsor: **Konkuk University Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Diagnostic Colonoscopy Screening

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Midazolam
- **DRUG:** Meperidine
- **DRUG:** placebo (for remifentanil)
- **DRUG:** placebo (for midazolam)
- **DRUG:** placebo (for meperidine)

## Key facts

- **NCT ID:** NCT01693185
- **Lead sponsor:** Konkuk University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-02
- **Final completion:** 2013-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01693185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01693185, "Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01693185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*